Millions to medical-tissue factory and digital infrastructure for health data

National Growth Fund supports two large consortia with roots in Maastricht

The RegMed XB partnership, which largely originates from Maastricht University (UM), will receive up to €56 million from the National Growth Fund to build a pilot plant for regenerative medicine. Of the total amount, €23 million was awarded outright and €33 million is subject to conditions. This was decided by the Cabinet on Friday. The Health RI alliance, which is developing a digital infrastructure for health data - another initiative with UM roots - will receive up to €69 million (€22 million subject to conditions, €47 million as a reserve). Additionally, the Brightlands AI hub, located on the Brightlands Smart Services Campus in Heerlen and jointly initiated by UM, will benefit from up to €276 million awarded by the National Growth Fund to the Netherlands AI Coalition.

regmed

Infrastructure for health data

The amount of data in the health sector is exploding, but due to organisational issues this health data cannot yet be put to optimal use in research and innovation. Large datasets are managed in fragments by different healthcare and research institutions. According to the assessment committee that advised the Cabinet, the corona crisis shines a spotlight on the need for an integrated, national infrastructure for health data. The aim of the Health RI initiative is to foster innovation in the health sector by standardising and synthesising data from Dutch hospitals and care organisations, knowledge institutions, public-health organisations, patient organisations, health funds and companies. “I’m extremely proud and happy that the importance of a solid health-data infrastructure has been recognised,” says André Dekker, professor of Clinical Data Sciences in Maastricht and one of the spiritual fathers of Health RI. “In the coming years, this will have enormous added value for our research as well as our patients.”

Personal Health Train

Dekker’s team was not only involved in founding the Health RI alliance, but also developed the Personal Health Train (PHT). Traditionally, medical data is collected and copied from one place to another. The PHT ‘comes’ to the required data, as it were. It can be envisaged as a kind of train (actually a search query or algorithm) that travels past various data stations to analyse the information held there. Because the data stays at the source, the owner retains control of it, making this a privacy-friendly way of handling medical data. “We developed the PHT in recent years with money from the Province of Limburg,” Dekker says. “Thanks to this injection from the National Growth Fund, we’ll now be able to apply the concept more widely.”

Also read

  • Why some people hesitate to vaccinate and how healthcare can address this

    Doubts about vaccination continue to be a significant challenge for global public health. The World Health Organisation (WHO) has listed vaccine hesitancy as one of the top ten threats to global health.  But what exactly is vaccine hesitancy and how does it impact our society? How can we address it...
    UM in the press
    foto
  • GROW research: all-in-one test for genetic defects in embryos🧪

    Researchers at Maastricht UMC+ and GROW have developed a technique that can analyse the entire genome in a single test, allowing for faster determination of embryos suitable for successful pregnancy.
    Researchers,
    UM in the press and
    UM news
  • Tears reveal more than emotion

    With the tear fluid research set up by Marlies Gijs, she is doing groundbreaking work.
    UM in the press